glp-1 stroke risk Efficacy of glucagon-like peptide-1 receptor agonists for prevention of among patients with and without diabetes: A meta-analysis with the SELECT and FLOW trails Benefits of GLP-1 (Glucagon-Like Peptide

Looking for Market Leaders Only two companies, Eli Lilly and Novo Nordisk, have sizable GLP-1s available today, and we expect them to dominate the market over the intermediate term

Papalia, F., Jouhra, F., Amin-Youssef, G., Shah, A

doi:10.3945/ajcn.2009.28449C 10

[DOI] [PubMed] [Google Scholar] 89.Enebo L.B., Berthelsen K.K., Kankam M., Lund M.T., Rubino D.M., Satylganova A., Lau D.C.W

First isolated and characterized in the early 1990s, this 15-amino acid peptide has garnered significant attention in preclinical research for its remarkable cytoprotective and regenerative properties across multiple organ systems

APPENDIX APPENDIX Internet Sites Data on ovarian cancer frequency IARC: American Cancer Society: National Cancer Institute: American Cancer Society: Gene-specific information GSTM1 Human Gene Mutation Database: OMIM: UniGene: GeneCards: GSTT1 Human Gene Mutation Database: OMIM: GeneCards: GSTP1 Human Gene Mutation Database OMIM UniGene GeneCards Rights and permissions About this article Cite this article Coughlin, S., Hall, I